Currently Browsing
Our Products
Aurobindo Receives FDA Approval for Niacin Extended-Release Tablets USP
Overview
- Reference Brand:
- Therapeutic Class:
Specifications
Order Information
Attributes
- Physical Form:
July 22, 2026 | Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% ... Read more
July 21, 2026 | Aurobindo Receives FDA Approval for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg ... Read more
July 15, 2026 | Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg ... Read more